Page last updated: 2024-10-26

dipyridamole and Cancer of Gastrointestinal Tract

dipyridamole has been researched along with Cancer of Gastrointestinal Tract in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"In the presence of a chronic consumption coagulopathy, it remains uncertain whether antiplatelet drugs are of prophylactic antithrombotic value."1.28Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis. ( Bouquet, J; Hofhuis, WJ; Oranje, AP; Sinaasappel, M, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hofhuis, WJ1
Oranje, AP1
Bouquet, J1
Sinaasappel, M1

Other Studies

1 other study available for dipyridamole and Cancer of Gastrointestinal Tract

ArticleYear
Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis.
    European journal of pediatrics, 1990, Volume: 149, Issue:8

    Topics: Anemia, Hemolytic; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Gastrointe

1990